Beta-Glucan (Yeast-Derived).
Trains your immune cells to respond faster and stronger. Trains innate immune cells (macrophages, neutrophils) to respond more effectively to pathogens. May reduce infection frequency and duration.
Reviewed March 2026
- Category
- Compound
- Also filed under
- Immune primingPathogen defenseRecovery
What Beta-Glucan (Yeast-Derived) is, and what it does.
- Does it work
- Good immune support option, especially for those who get frequent colds. Evidence is solid for reducing upper respiratory infections.
- How much to take
- 250-500mg daily of beta-1,3/1,6-glucan. Quality and form matter more than raw amount.
- Time to feel it
- Nothing on the tongue or in the gut. Trials of this form track innate immune measures across four to twelve weeks of daily use, so the change is a slow one.
- The first dose
- No noticeable effects. Works by training immune cells over time.
- With regular use
- Potentially fewer colds and infections. Faster recovery when sick.
- How well tolerated
- Well tolerated. Non-allergenic despite coming from yeast.
- How it feels
- Nothing acute. Benefits show up as fewer sick days over months.
- The overlooked benefit
- It isn't absorbed into the blood. Particles are sampled by immune tissue in the gut wall, so a plasma level would tell you nothing about whether it's reaching its target.
100 to 250mg a day is where Beta-Glucan (Yeast-Derived) works.
Source: Saeed et al. 2021 Nutrients review; Bashir & Choi 2017 Int J Mol Sci.
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
Beta-Glucan (Yeast-Derived) has emerging evidence. Based on 7816+ studies.
- innate immune cell recognition through dectin-1In vitro study
- immune resilience through the colder monthsRandomised trial
- immune markers during heavy physical trainingRandomised trial
- fermentation to short-chain fatty acids in the colonIn vitro study
Questions people ask about Beta-Glucan (Yeast-Derived).
- When should I take it?
- Timing matters less than consistency. Pick a time that works for you and take it daily.
- Can I take it with other supplements?
- Usually fine. The main thing to watch is not doubling up on the same ingredient from different products. If you're on prescription meds, check with your pharmacist first.
- Any side effects to watch for?
- Most people tolerate it well at recommended doses. GI upset is the most common complaint with any supplement. Start with a lower dose and work up. If something feels off, stop and reassess.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Zinc is a required cofactor for the development and signaling of the macrophages, neutrophils and natural killer cells that yeast beta-glucan primes through Dectin-1. Beta-glucan switches these innate cells into a ready state while zinc supplies what they need to carry out normal immune function.
Vitamin C concentrates inside neutrophils and supports their chemotaxis and oxidative burst, the same phagocytes yeast beta-glucan primes via pattern-recognition receptors. The two act on one set of effector cells from different angles to support normal immune defense.
Vitamin D signaling tunes how monocytes and macrophages respond and supports their antimicrobial peptide output, and these are the innate cells yeast beta-glucan engages. The pairing supports normal function of the same frontline immune compartment through complementary routes.
Both supply beta-1,3/1,6-glucans recognised by Dectin-1 and complement receptor 3 on innate immune cells. Because they act at the same receptors, combining them is additive on one pathway rather than two.
Turkey tail's polysaccharide fraction is also a beta-glucan recognised by the same innate receptors, so the two share their mechanism of recognition. Blends stack the same signal with different protein-bound carriers.
Reishi contributes beta-glucans that act at Dectin-1 alongside triterpenes that work by a separate route. The glucan halves overlap while the triterpene fraction adds something the yeast glucan does not carry.
Astragalus polysaccharides act on pattern recognition receptors on innate cells, a related but not identical route to Dectin-1 recognition of yeast glucan. The pairing is long-standing in seasonal formulas.
Echinacea's alkylamides act on cannabinoid type 2 receptors on immune cells while its polysaccharides act on innate receptors, so the mechanism only partly overlaps with yeast glucan. The two are combined routinely for that reason.
Colostrum supplies immunoglobulins and lactoferrin that act directly at the mucosal surface, while yeast glucan primes the innate cells behind it. The two contribute different layers rather than the same one.
Yeast beta-glucan is sampled by immune cells in gut lymphoid tissue, and the resident microbial community shapes how that tissue responds. Formulas pair them so the signal and its context arrive together.
Selenium is built into the selenoproteins that manage oxidative load inside activated immune cells. Adequate selenium supports the cells that yeast glucan is priming.
Glutamine is a preferred fuel for enterocytes and for rapidly dividing lymphocytes, the same cells that respond to glucan recognition. It supplies substrate rather than a second signal.
Retinoic acid guides differentiation of immune cells in gut-associated tissue and maintains the mucosal barrier where glucan is sampled. The relationship is well described physiologically but the pairing itself is little studied.
Oat beta-glucan is a linear soluble 1,3/1,4 polymer that raises the viscosity of gut contents. Yeast beta-glucan is a branched 1,3/1,6 particulate that is largely insoluble and is taken up by gut-associated myeloid cells. Formulas that carry both are covering two different behaviours of the same class rather than doubling one. The distinction is structural chemistry, not a comparative clinical finding.
Psyllium forms a gel that slows the mixing of bile acids with dietary fat, and soluble glucan fractions add to that viscosity. The combination is used to support normal blood lipid levels already in the normal range. Yeast-derived glucan contributes less viscosity than cereal glucan because most of it stays particulate. The pairing is a fibre-matrix effect rather than an immune one.
Human digestive enzymes do not cleave beta-1,3/1,6 linkages or inulin's fructan bonds, so both arrive in the colon intact. Colonic bacteria ferment them to short-chain fatty acids. Inulin is the faster substrate and glucan the slower one, which spreads fermentation along the colon. Gas and bloating rise with total fermentable load, so a combined dose behaves like a larger single dose.
FOS is fermented rapidly in the proximal colon while yeast glucan is fermented slowly and incompletely. Stacking them broadens the substrate window for short-chain fatty acid production. The trade-off is the same as with any fermentable pair: more total gas early in the colon.
GOS supports bifidobacteria specifically; glucan fermentation is broader and slower. Together they feed different parts of the community. This is a substrate argument from established carbohydrate biochemistry rather than a combination trial result.
Resistant starch is a strong butyrate substrate and glucan fermentation yields a mixed short-chain fatty acid profile. Pairing them raises total colonic substrate without raising rapidly fermented sugar load. Tolerance sets the practical ceiling.
Colonic bacteria convert fermentable glucan fractions into short-chain fatty acids including butyrate, which colonocytes use as fuel. A supplemental butyrate salt delivers the end product directly while glucan supplies substrate for endogenous production. The two arrive at the same molecule by different routes and their timing differs.
S. boulardii cell walls contain the same beta-1,3/1,6 architecture found in purified yeast glucan, so the pairing overlaps in composition as well as in gut behaviour. The live organism also transits and interacts with the mucosa. Read the overlap as compositional rather than as a tested combination.
Glucan fractions that reach the colon intact become substrate for resident and supplemented bacteria. L. plantarum is commonly co-formulated on that basis. The strength of the pairing depends on the strain's own glycoside hydrolase repertoire, which varies.
Bifidobacteria are efficient at using complex non-digestible carbohydrates. Formulators pair yeast glucan with B. longum to give the organism substrate on arrival. This is a substrate-plus-organism design argument, not an outcome measured for this specific pair.
Lactoferrin binds iron and interacts with mucosal surfaces; yeast glucan engages pattern-recognition receptors on myeloid cells. They support normal immune function through separate handles, which is why they appear together in the same formulas. No shared absorption step links them.
Elderberry contributes anthocyanins and yeast glucan contributes a cell-wall polysaccharide. The pairing is a formulation convention in seasonal products rather than a combination with a measured joint effect. Read it as practice, not evidence.
Propolis brings a polyphenol and flavonoid mix; glucan brings a polysaccharide. The two do not compete for absorption because glucan is barely absorbed at all. The combination is formulation practice with no measured joint outcome to point to.
Quercetin is a flavonoid with antioxidant behaviour in laboratory work; glucan acts through receptor recognition on innate immune cells. Their overlap is thematic rather than biochemical. Treatment of this as complementary is a formulation judgement.
Glucomannan is highly viscous and glucan fractions add to gel formation in the stomach and small intestine. That raises the same trade-off both carry alone: slowed gastric emptying and a need for adequate fluid. Total viscous fibre load is what matters, not which one supplies it.
Soluble glucan fractions bind bile acids in the gut lumen and carry a portion out in stool. Supplemental ox bile is taken to add bile acids for fat emulsification. Taken in the same dose, one works against the intent of the other. Separating them by a couple of hours is the usual formulation answer.
Gel-forming fibres can slow the diffusion of minerals to the absorptive surface. The size of that effect for yeast-derived glucan specifically has not been established, and much of the material is particulate rather than gel-forming. Spacing an iron dose away from a large fibre dose is a conservative practice, not a documented requirement.
Carotenoid uptake needs dietary fat and bile to form mixed micelles. High viscous fibre loads slow that process and bind some bile acids. The effect has been described for cereal fibre more than for yeast glucan, so read this as a mechanistic caution at low confidence.
Nothing specific on file for Beta-Glucan (Yeast-Derived). Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What Beta-Glucan (Yeast-Derived) actually does.
Yeast beta-glucan is a beta-1,3-linked glucose backbone with beta-1,6 branches, isolated from the cell wall of Saccharomyces cerevisiae. The branching pattern is what distinguishes it from the linear beta-1,3/1,4 glucan of oats and barley.
Human digestive enzymes cannot hydrolyse beta-1,3 or beta-1,6 glucosidic bonds, so the polymer passes the small intestine essentially intact.
Beta-1,3/1,6 glucans are recognised by dectin-1, a C-type lectin receptor expressed on macrophages, monocytes, neutrophils and dendritic cells, and by complement receptor 3. This receptor recognition is the reason yeast glucan is studied as an innate immune modulator rather than as a fibre.
Yeast cell wall preparations carry mannan and chitin alongside glucan unless purified, so composition varies with the extraction route and a labelled percentage refers to glucan content rather than to the whole material.
Where Beta-Glucan (Yeast-Derived) comes from.
It comes from the cell wall of ordinary baker's yeast. The yeast is broken open, the soft interior and most of the other wall components are washed away, and what remains is dried into a powder. How thoroughly it is washed decides how pure it is.
Produced by a cultured organism rather than harvested. The strain is selected and the conditions are controlled, so batches sit closer together than a field crop.
Saccharomyces cerevisiae grown on a sugar substrate, or recovered as spent yeast from brewing.
Cells are lysed so the soluble interior can be separated from the insoluble cell wall fraction.
Sequential alkaline and acid treatment removes protein, lipid and much of the mannan, leaving the beta-1,3/1,6 glucan skeleton.
Residual reagents are washed out and the slurry is neutralised before drying.
Material is assayed for beta-glucan percentage, which is what a label claim refers to rather than total cell wall weight.
Dried to a free-flowing powder for capsules, tablets and powder blends.
Getting Beta-Glucan (Yeast-Derived) from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
The essence, in one line each.
- In 98 adults aged 50 to 70 taking 250 mg of yeast beta-1,3/1,6-glucan daily through winter, confirmed upper respiratory episodes were 17 versus 28 on placebo, a difference that did not reach statistical significance (odds ratio 0.55, 95 percent CI 0.24 to 1.26).Randomised trial. Fuller et al., 2017 (Nutrition). PMID 28606567 ↗
- Twelve weeks of 250 mg baker's yeast beta-glucan daily in 77 women under moderate psychological stress was linked to fewer reported upper respiratory symptoms (10 percent versus 29 percent on placebo) and better self-reported mood and vigour scores.Randomised trial. Talbott and Talbott, 2012 (Journal of the American College of Nutrition). PMID 23378458 ↗
- Marathon runners drinking a beverage with 250 mg dispersible yeast beta-glucan daily for 91 days reported fewer upper respiratory symptom days (3.43 versus 3.84) and lower total symptom severity than controls, with no difference in the number or duration of episodes.Randomised trial. Mah et al., 2018 (Journal of Dietary Supplements). PMID 30380356 ↗
- Comparing forms head to head in 278 marathon runners, insoluble yeast beta-glucan lowered total upper respiratory symptom severity and symptom days versus placebo while the soluble form did not, though both lowered nasal discharge severity.Randomised trial. Mah et al., 2019 (Journal of Medicinal Food). PMID 31573387 ↗
- In healthy adults, daily beta-1,3/1,6-glucan from baker's yeast supported markers of mucosal immune activity in the upper airway compared with placebo.Randomised trial. Kanno et al., 2026 (Nutrients). PMID 41901136 ↗
- Eight weeks of a yeast cell-derived supplement shifted antioxidant and immune response markers relative to placebo in the adults studied.Randomised trial. König et al., 2026 (Nutrients). PMID 42197007 ↗
- Reports a randomised evaluation of yeast beta-1,3/1,6 glucan supplementation in adults, with respiratory symptom frequency, fatigue, immune markers and gut measures as the stated endpoints.Randomised trial. Mohamad Habibullah NN et al., 2025 (BMJ Open). PMID 39832981 ↗
- A randomised evaluation of a food-industry by-product beta-glucan with chitin-chitosan on blood lipid measures; the endpoints are markers, not clinical events.Randomised trial. Santisteban V et al., 2024 (Nutrients). PMID 39408385 ↗
- Reviews fungal beta-1,3-glucans as cell wall constituents that interact with innate immune recognition and with the gut environment.Narrative review. Samiksha F et al., 2026 (Nutrients). PMID 42280437 ↗
- Reports that yeast beta-glucan supplementation reshaped myeloid immunometabolism in a mouse model; the work is mechanistic and non-human.Animal study. Ledwith AE et al., 2026 (Cell Reports). PMID 42397745 ↗
- Compares beta-1,3/1,6-glucan oligosaccharide and polysaccharide fractions on tolerance and lipid measures in a preclinical model, and reports that the two fractions behaved differently.Animal study. Rungraung N et al., 2026 (Food Science and Nutrition). PMID 41783691 ↗
- Reports functional outcomes beyond immune markers for dietary yeast and seaweed beta-glucans in adult dogs.Animal study. Theodoro SS et al., 2026 (Journal of Animal Physiology and Animal Nutrition). PMID 42152695 ↗
- Examines the prebiotic potential of glucans combined with goat's milk in cats.Animal study. Han B et al., 2025 (Canadian Journal of Veterinary Research). PMID 39744467 ↗
- Reports that dietary beta-glucan supplementation blunted heat stress related declines in performance, egg quality and intestinal measures in laying hens.Animal study. Abuajamieh M et al., 2026 (Veterinary World). PMID 42494684 ↗
- Reports that the duration of beta-1,3/1,6-glucan administration tracked with the degree of immune stimulation measured in juvenile fish.Animal study. Kazuń B et al., 2026 (Journal of Veterinary Research). PMID 42440786 ↗
- Reports strain-specific differences between yeast polysaccharide preparations on growth, antioxidant and immune measures in fish, which is a reminder that yeast source strain matters.Animal study. Yuan R et al., 2026 (Aquaculture Nutrition). PMID 42137134 ↗
- A randomised evaluation of chronic barley consumption on upper respiratory tract symptoms in healthy Japanese adults; the beta-glucan here is cereal-derived, not yeast-derived.Randomised trial. Araki R et al., 2024 (Nutrients). PMID 39064742 ↗
These are the studies our verdict leans on, chosen from the 30 we read for Beta-Glucan (Yeast-Derived). The full linked list is below.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.